Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.36% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.08% |
| 4 | Healthcare | 0.89% |
| 5 | Communication Services | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCS
11201
PIMCO Strategic Income Fund
RCS
$249M
| $54.9K | ﹤0.01% |
+10,332
| New | +$56.7K |
|
11202
CALL
Harvard Bioscience
HBIO
$34.5M
| $54.6K | ﹤0.01% |
1,270
-230
| -15% | -$10.6K |
|
|
CONN
11203
PUT
DELISTED
Conn's Inc.
CONN
| $54.5K | ﹤0.01% |
13,800
-12,800
| -48% | -$53.1K |
|
11204
Clear Channel Outdoor Holdings
CCO
$1.21B
| $54.5K | ﹤0.01% |
34,472
-99,116
| -74% | -$150K |
|
11205
PUT
Organogenesis Holdings
ORGO
$220M
| $54.4K | ﹤0.01% |
17,100
-89,000
| -84% | -$283K |
|
11206
PUT
Cue Biopharma
CUE
$195M
| $54.3K | ﹤0.01% |
+787
| New | +$76.8K |
|
|
OLPX
11207
PUT
DELISTED
Olaplex Holdings
OLPX
| $54K | ﹤0.01% |
27,700
-11,600
| -30% | -$34.9K |
|
11208
PUT
CEL-SCI Corp
CVM
$28.3M
| $54K | ﹤0.01% |
1,440
-1,623
| -53% | -$77.6K |
|
|
GRRR
11209
Gorilla Technology Group
GRRR
$423M
| $54K | ﹤0.01% |
+6,213
| New | +$125K |
|
11210
LiveOne
LVO
$52.5M
| $54K | ﹤0.01% |
5,643
-1,205
| -18% | -$19.1K |
|
11211
Globus Maritime Ltd
GLBS
$80.1M
| $53.9K | ﹤0.01% |
29,287
-12,530
| -30% | -$12.4K |
|
11212
Idaho Strategic Resources
IDR
$527M
| $53.7K | ﹤0.01% |
10,657
-4,067
| -28% | -$22.1K |
|
11213
OptimumBank Holdings
OPHC
$118M
| $53.3K | ﹤0.01% |
+16,829
| New | +$51.8K |
|
11214
PUT
Veru
VERU
$47.2M
| $53.3K | ﹤0.01% |
7,400
-22,280
| -75% | -$243K |
|
|
TALK
11215
CALL
DELISTED
Talkspace
TALK
| $53.2K | ﹤0.01% |
+27,300
| New | +$43.8K |
|
11216
Design Therapeutics
DSGN
$979M
| $53.2K | ﹤0.01% |
22,537
-34,257
| -60% | -$160K |
|
11217
PUT
TH International
THCH
$40M
| $53K | ﹤0.01% |
5,860
-61,500
| -91% | -$744K |
|
11218
Comstock
LODE
$263M
| $53K | ﹤0.01% |
12,920
+5,587
| +76% | +$29K |
|
11219
PUT
Solid Power
SLDP
$532M
| $52.9K | ﹤0.01% |
26,200
+7,600
| +41% | +$18K |
|
11220
Destination XL Group
DXLG
$35M
| $52.8K | ﹤0.01% |
11,796
-5,711
| -33% | -$26.8K |
|
11221
ProQR Therapeutics
PRQR
$326M
| $52.8K | ﹤0.01% |
+40,610
| New | +$63.9K |
|
|
CANO
11222
PUT
DELISTED
Cano Health, Inc.
CANO
| $52.7K | ﹤0.01% |
2,107
-1,363
| -39% | -$112K |
|
11223
PUT
Valens Semiconductor
VLN
$196M
| $52.4K | ﹤0.01% |
+19,700
| New | +$49.5K |
|
|
ASXC
11224
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
| $52.4K | ﹤0.01% |
193,900
-7,400
| -4% | -$2.69K |
|
|
GOL
11225
CALL
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $52.3K | ﹤0.01% |
19,100
-6,500
| -25% | -$23K |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.